tradepost.ai Logo
Newsletter InsightsSEC AnalysisAI Top20 IndexPricing
Log in
Start free trial
tradepost.ai Logo

Empowering Traders with AI

Quick Links

Newsletter InsightsSEC AnalysisPricingFAQ

Legal

Privacy PolicyCookies PolicySecurity Disclosure PolicyTerms & ConditionsDisclaimer

Copyright © 2025 Dutchcode B.V. All rights reserved.

10-Q - Akari Therapeutics Plc (0001541157) (Filer)

Wed, May 14, 8:56 PM (39 days ago)

**Akari Therapeutics, Plc (AKTX) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** No revenue generated; Akari is in the development stage. - **Net Loss:** $3.7 million, a 34% improvement from $5.6 million in Q1 2024. - **Operating Expenses:** $3.5 million, down 41% from $6.0 million in Q1 2024. - **R&D Expenses:** $813,000, down 64% from $2.3 million in Q1 2024. - **G&A Expenses:** $2.7 million, down 27% from $3.7 million in Q1 2024. - **Cash Position:** $2.6 million, sufficient to fund operations into September 2025. - **Accumulated Deficit:** $251.0 million, reflecting substantial historical losses. - **Cash Flow:** Net cash used in operations was $2.2 million, an improvement from $4.0 million in Q1 2024. **Key Metrics and Trends:** - **Profit Margins:** Negative, with significant operating losses. - **Cash Flow:** Negative, with cash used in operations, but improved from the previous year. - **Earnings Changes:** Net loss improved by 34% year-over-year. - **Quarterly Performance:** Reduced operating expenses and improved cash flow management. - **Uncertainties:** Substantial doubt about the ability to continue as a going concern, requiring additional funding. **Future Operations and Impact:** - **Funding:** Akari needs additional capital to continue operations and meet obligations. - **Strategic Moves:** Focus on ADC platform and pipeline, seeking strategic partners and collaborations. - **Risk Factors:** Dependence on key individuals, uncertainty of product development, and need for additional funding. **Conclusion:** Akari Therapeutics, Plc showed improved financial management in Q1 2025, with reduced operating expenses and better cash flow. However, the company faces significant challenges, including substantial historical losses, a negative cash position, and the need for additional funding to continue operations. The focus on the ADC platform and strategic partnerships is crucial for future growth and sustainability.